Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions
Pranam Chatterjee et al. present a novel computational platform for engineering peptide fusions that bind to the SARS-CoV-2 spike protein and tag it for proteasomal degradation. They experimentally validate an optimal variant in human cells, showing that it inhibits production of infection-competent...
Guardado en:
Autores principales: | Pranam Chatterjee, Manvitha Ponnapati, Christian Kramme, Alexandru M. Plesa, George M. Church, Joseph M. Jacobson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c38f96c2ae5f4bc7940b60f8c64fa945 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunoreactive peptide maps of SARS-CoV-2
por: Nischay Mishra, et al.
Publicado: (2021) -
Intracellular delivery of cell-penetrating peptide-transcriptional factor fusion protein and its role in selective osteogenesis
por: Suh JS, et al.
Publicado: (2014) -
Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor
por: Thassanai Sitthiyotha, et al.
Publicado: (2021) -
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
por: Xiaoyi Fan, et al.
Publicado: (2020) -
Development and Characterization of Magnetic SARS-CoV-2 Peptide-Imprinted Polymers
por: Beatriz Fresco-Cala, et al.
Publicado: (2021)